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subtype, tumour staging (according to TNM classifi cation) 
and grading (according to Fuhrman nuclear grading sys-
tem). The histological subtype was divided into clear-cell 
RCC, chromophobe, papillary and others type of tumours. 
Written informed consent and approval was obtained from 
all participants. The study was in adherence with the Dec-
laration of Helsinki.
Results
During the aforementioned period we were treating 
634 patients with RCC. Among all the patients 197 (31.1%) 
were 70 years old or older. The number of elderly patients 
increased during the period (Table 1). In the elderly group 
there were 117 (59.4%) men and 80 (40.6%) women. The 
tumor was slightly predominating on the left side (105 
patients – 53.3%). Radical nephrectomy was performed in 
103 (52.3%) patients, simple nephrectomy in 86 patients 
(43.7%), nephron-sparing surgery (partial nephrectomy or 
enucleation of the tumour) in 6 (3.1%) patients, while in 2 
patients the tumour was inoperable. Histologically, the 
most common subtype of tumour was clear cell RCC diag-
nosed in 156 patients 79.2% (Table 2). According to TNM 
classifi cation the dominant stage was T1 in 110 patients 
(55.9%) and the most common grade was G2 (73 patients 
Renal cell cancer (RCC) is the most common type of 
kidney cancer. In the USA estimated number of new cases 
is 64,770 with 13,570 deaths in 20121. The incidence of 
RCC increased during the last decades2,3. The reason for 
the increased incidence is aging population and wide-
spread use of diagnostic imaging modalities. More than 
70% of patients have localized form of disease and can be 
treated surgically. The standard treatment for localized 
RCC is still nephrectomy or nephron-sparing surgery. The 
number of elderly patients increased in the last decades 
due to newly discovered cancers including RCC4. We in-
vestigated surgical treatment of RCC in the elderly pa-
tients from our center.
Patients and methods
We retrospectively analyzed data about our patients 
undergoing surgery for RCC from January 2000 to De-
cember 2012 in the Department of Urology, University 
Hospital Rijeka. The patients’ records were evaluated us-
ing information about the patients’ age, gender, type of 
operation, pathological fi ndings, complications and sur-
vival. We separated the patients according to their age, 
where term »elderly« was defi ned as age of 70 or older. 
From pathological fi ndings we determined the histological 
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A B S T R A C T
The aim of this study was to analyze our patients over the age of 70 suffering from kidney cancer that had undergone 
surgical treatment. During the 2000–2012 period 634 patients with kidney cancer were treated, 197 of whom were over 
the age of 70. In this group there were 117 (59.4%) men and 80 (40.6%) women. In most of these patients (156 patients – 
79.2%) the clear cell type of renal carcinoma was diagnosed. According to TNM classifi cation the dominant stages were 
T1b in 62 patients (31.8%) and T1a in 48 patients (24.6%). The most common grade was G2 (73 patients – 37%). Radical 
nephrectomy was performed in 103 (52.3%) patients, simple nephrectomy in 86 patients (43.7%), enucleation of the tumor 
and resection of the kidney in 6 (3.1%) patients, while in 2 patients the tumor was inoperable. Early postoperative compli-
cations developed in 21 (10.8%) patients. They included complications in distant organs in 11 (5.6%) patients and surgical 
complications in 10 (5.4%) patients. Five patients (2.6%) died during early postoperative period. Surgery is recommended 
treatment for elderly patients with kidney cancer with complications comparable with those in younger patients.
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– 37%) (Tables 3 and 4). Early postoperative complications 
developed in 21 (10.8%) patients. They included complica-
tions in distant organs in 11 (5.6%) patients and surgical 
complications in 10 (5.4%) patients. Surgical complications 
consisted of secondary wound healing (5 patients), bleed-
ing (2 pts), ileus (1 pt) and splenectomy (1 pt). Distant 
complications included: myocardial infarction (4 pts), 
pneumonia (4 pts), cardiac arrest (1 pt), pulmonary embo-
lism (1 pt) and pulmonary oedema (1 pt). Five patients 
(2.6%) died during early postoperative period.
Discussion
The life span of the individual is increasing worldwide 
due to major progress in healthcare. The population aged 
65–84 will double from the year 2000 to 2050 and at the 
same time the elderly over the age of 85 will increase from 
4.2 million to 20.8 million people. The ageing population 
will have an important impact on medical practice. Near-
ly all urologic diseases, including the urologic cancers, 
increase with age5.
RCC is the third most common urological cancer affect-
ing about 3% of all adult population with predominance of 
men. Peak incidence is occurring between the ages of 60 
and 70. Etiological factors includ lifestyle factors smoking, 
obesity and hypertension6. Many renal masses remain 
asymptomatic until the late stages of the disease. Cur-
rently, more than 50% of RCCs are detected incidentally 
when non-invasive imaging is used to investigate a variety 
of nonspecifi c symptoms and other abdominal diseases7. 
The classic triad of fl ank pain, gross hematuria nad pal-
pable mass is now rare (up to 10% of patients). The same 
trend was seen in our patients where most of the patients 
were asymptomatic.
The general assessment of the patient in fi nding prop-
er treatment modality is very important. This is espe-
cially true in elderly patients needing surgical treatment. 
Specifi c preoperative assessment using the American So-
ciety of Anesthesiologists’ score (ASA score) may help to 
predict the morbidity of surgery8. The study on 1,023 pa-
tients with RCC showed that younger patients had lower 
ASA score9. Perioperative mortality was higher in the 
older patients but intraoperative and early postoperative 
complications were not increased. The morbidity and mor-
tality wre found to correlate with increasing ASA score, 
not to age.
In the elderly comprehensive geriatric assessment 
(CGA) can be used to help making therapeutic decision10. 
The objective of CGA is to improve diagnostic accuracy 
and optimize medical treatment and health outcome. With 
this evaluation patients are divided in the three groups: 
patients who should be treated like young patients, vul-
nerable patients and frail patients. Management should 
be individualized and should take into consideration the 
life expectancy and the preferences of the patient.
Most of the patients (75%) in our study had localized 
tumour (stage T1 and T2). Historically the curative treat-
ment of localized RCC has been radical nephrectomy. This 
procedure can be done by open surgery, laparoscopic tech-
nique or using the robot. The overall reported complica-
tions rate in the patients over 75 years are up to 22.6%11. 
With our 10.8% we are in the expected range but improve-
ment can be done. One possibility is introduction of lapa-
roscopic procedures that decrease blood loss, transfusion 
rate, pain and hospital stay.
Nephrectomy diminishes nephron mass and have po-
tentially negative impact on renal function leading to 
chronic kidney disease. Patients who had developed chron-
ic kidney disease have increased cardiovascular morbid-
ity and mortality. In our previous study of patients under-
TABLE 1
DISTRIBUTION OF 197 PATIENTS ≥70 YEARS OLD OPERATED DUE TO RENAL CELL CANCER (2000–2012)
Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
No. of patients 11 13 10 10 17 17 12 18 19 16 16 21 17
TABLE 2
HYSTOLOGICAL TYPE OF RENAL CELL CANCER IN ELDERLY 
PATIENTS (N=197)
Hystological type No. of patients (%)
Clear-cell renal cell cancer 156 (79.2%)
Papillary renal cell cancer   26 (13.2%)
Chromophobe renal cell cancer  10 (5.1%)
Others (oncocytoma, Bellini, planocellulare)   5 (2.5%)
TABLE 3
TNM CLASSIFICATION IN ELDERLY PATIENTS WITH RENAL 
CELL CANCER (N=197)
TNM classifi cation No. of patients (%)
T1 110 (55.9%)
T2  37 (18.8%)
T3  48 (24.3%)
T4 2 (1%)0
TABLE 4
CLASSIFICATION OF THE RENAL CELL CANCER ACCORDING 
TO GRADING IN ELDERLY PATIENTS (N=197)
Tumour grading No. of patients (%)
G1 43 (21.8%)
G2 73 (37.1%)
G3 59 (29.9%)
G4 22 (11.2%)
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going nephrectomy for RCC the mean preoperative 
estimated glomerular fi ltration rate (eGFR) in the patients 
≥65 years was lower comparing to younger patients12. In 
the older group the mean preoperative eGFR was 69.2 mL/
min and the mean postoperative eGFR was 47.4 mL/min 
comparing to 79.8 mL/min and 57.2 mL/min in the young-
er patients. It is obviously that in the elderly patients di-
minishing of renal function following nephrectomy is more 
prominent. These patients had more chance to develop 
chronic kidney disease which infl uence on quality of life, 
morbidity and mortality.
Hellenthal analysed Surveillance, Epidemiology, and 
End Results database with 59,944 patients who under-
went partial or radical nephrectomy for RCC between 
1988 and 2005 with special emphasis on the octogeneri-
ans13. The 4,227 (7.5%) of patients were over 80 years old. 
Older patients are less likely to undergo partial nephrec-
tomy than younger counterparts. In this study the RCC 
related death rate was similiar in both younger and older 
patients (15% vs 17%). Older patients were approximately 
2.3 times more likely to die from other causes than RCC 
confi rming their frail nature. Also octogenerians treated 
with partial nephrectomy are less likely to die of RCC 
than those who undergo radical nephrectomy.
To prevent development of kidney failure nephron-
sparing procedures are advocated in patients with local-
ized tumour. More than 60% of newly discovered RCCs 
are 4 cm or les in diameter which means that they are 
amenable for partial nephrectomy. Nephron-sparing sur-
gery and total nephrectomy is equally effective in patients 
with T1 RCC with regard to cancer-specifi c survival14. 
Nephron-sparing surgery should be the treatment of 
choice in patients with existing renal dysfunction or in the 
paients with recognized risk factors (elderly, proteinuria, 
diabetes) including oncologic outcome, as well. Since the 
number of partial nephrectomies has been low in our 
study by increasing the number of these operations we can 
improve quality of life of our patients.
Conclusion
The RCC affected people of different age including the 
elderly. In most of the patients tumour was asymptomatic 
and localized to the kidney. The use of nephron-sparing 
procedures and minimally invasive surgery can diminish 
rate of complications and improve the survival.
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KIRURŠKO LIJEČENJE KARCINOMA BUBREGA U OSOBA STARIJE DOBI
S A Ž E T A K
Cilj rada je prikazati naša iskustva u kirurškom liječenju bolesnika s karcinomom bubrega starijih od 70 godina. Tijekom 
12 godina (2000–2012.) liječili smo 634 bolesnika s karcinomom bubrega, od kojih je njih 197 bilo starije od 70 godina. U 
toj grupi starijih bolesnika bilo je 117 (59,4%) muškaraca i 80 (40,6%) žena. U većine bolesnika (156 bolesnika – 79,2%) 
pronađen je svjetlostanični karcinom bubrega. Prema TNM klasifi kaciji bolesnici su najčešće imali stadij T1b (62 bole-
snika – 31,8%) i T1a (48 bolesnika – 24,6%), a najčešći gradus je bio G2 u 73 bolesnika (37%). Radikalna nefrektomija je 
bila učinjena u 103 (52,3%) bolesnika, nefrektomija u 86 (43,7%) bolesnika, enukleacija tumora i resekcija bubrega u 6 
(3,1%) bolesnika, dok je u 2 bolesnika tumor bio inoperabilan. Rane poslijeoperacijske komplikacije su bile prisutne u 21 
(10,8%) bolesnika. U 11 (5,6%) bolesnika radilo se o komplikacijama na udaljenim organima te o kirurškim komplikaci-
jama u 10 (5,4%) bolesnika. U ranom poslijeoperacijskom razdoblju je umrlo 5 (2,6%) bolesnika. U bolesnika starije dobe s 
karcinomom bubrega kirurško liječenje je osnov liječenja, a komplikacije su usporedive s onima u mlađoj populaciji.
